Mefloqe 250 Tablet contains Mefloquine 250mg, a potent antimalarial medication indicated for the treatment and prophylaxis of malaria caused by Plasmodium species, including chloroquine-resistant strains. It helps in reducing parasite load and preventing the recurrence of infection.
Mefloquine works by interfering with the growth and reproduction of malaria parasites in red blood cells, ensuring effective treatment and prevention. Its long half-life makes it suitable for both therapy and prophylactic use in endemic regions.
For distributors and healthcare suppliers, Mefloqe 250 Tablet is a high-demand antimalarial product, widely used in hospitals, clinics, travel medicine, and community health programs. Seasonal malaria prevalence and international travel increase consistent market demand.
Adding Mefloqe 250 Tablet to your antimalarial and parasitic infection therapy segment creates strong opportunities in pharmacies, hospitals, travel clinics, export markets, and third-party manufacturing. Its proven efficacy, wide therapeutic application, and strong prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.